Safety and Efficacy Evaluation of Sugammadex in Cardiac Patients (19.4.309)(P05934)
Clinical trial NCT00420680 · COMPLETED
Trial details
- NCT number
- NCT00420680
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-07
- Primary completion
- 2006-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.